MarkNtel Advisors has thoughtfully curated the Global Solid Tumor Testing Market Research Report, taking into account our client's distinct needs. Our research offers a thorough examination of the present regional and global market conditions. This report on industry analysis extensively encompasses market dynamics, limitations, and their potential consequences on future market requirements, presenting a comprehensive overview of the sector.
What
is the projected growth rate of the Global Solid Tumor Testing Market during
the forecast period?
The Global Solid Tumor Testing Market size
is projected to grow at a CAGR of around 8.0% during the forecast period,
2023-28
In case you missed it, we are
currently revising our reports. Click on the "request sample report"
button to get the most latest research data with forecast for years 2024 to
2029, including market size, industry trends, and competitive analysis. It
wouldn't take long for the team to deliver the most recent version of the
report.
To
gain access to our Sample Report, please visit :- https://www.marknteladvisors.com/query/request-sample/solid-tumor-testing-market.html
Global
Solid Tumor Testing Market Driver:
Mounting Incidence of Cancer to Augment the
Market Growth – The rising number of cancer patients in the world is the
leading cause of the Global Solid Tumor Testing Market growth. The increasing
geriatric population coupled with a sedentary lifestyle & other hereditary
risk factors, are the major factors for the spike of cancer cases worldwide.
For instance, the recent incidence trends projected by the American Cancer
Society for FY2021 indicate a slight boost of nearly 2.50% compared to the
earlier projections being postulated for FY2020.
The
report has segmented the market into the following categories:
-By
Cancer Type
-Prostate Cancer
-Breast Cancer
-Colorectal Cancer
-Endometrial Cancer
-Melanoma
-Lung Cancer
-Thyroid Cancer
-Brain Cancer
-Ovarian Cancer
-Liver Cancer
-Other Cancer Types
-By
Application
-Clinical
-Diagnostics
-Treatment and Monitoring
-Screening
-Prognostics
-Research
-Biomarker Discovery
-Personalized Medicine
-By
End Users
-Hospitals, Diagnostic Laboratories, and
Reference Laboratories
-Pharmaceutical & Biotechnology
Companies
-Contract Research Organizations (CROs)
-Academic Research Institutions
-Other End Users
-By
Technologies
-In Situ Hybridization
-Immunohistochemistry
-Polymerase Chain Reaction
-Next-Generation Sequencing
-Other Technologies (Microarray, ELISA, and
LC/MS)
For
the full report, please follow this link:- https://www.marknteladvisors.com/research-library/solid-tumor-testing-market.html
-By
Region
-North America
-South America
-Europe
-Asia-Pacific
-The Middle East & Africa
Competitive
Landscape with Key Player:
Abbott Laboratories, ARUP Laboratories,
ASURAGEN, INC., Bio-Rad Laboratories, Inc, Beijing Genomics Institute (BGI)
Genomics Co., Ltd, F. Hoffmann-La Roche Ltd, Guardant Health, Illumina, Inc.,
Invivoscribe, Inc., Invitae Corporation, Laboratory Corporation of America
Holdings, NeoGenomics Laboratories, Inc., Opko Health, OmniSeq, QIAGEN N.V,
Quest Diagnostics Inc, Others
Talk
to our Expertise - https://www.marknteladvisors.com/query/talk-to-our-consultant/solid-tumor-testing-market.html
About
Us:
MarkNtel Advisors is a leading research,
consulting, & data analytics firm that provides an extensive range of
strategic reports on diverse industry verticals. We deliver data to a
substantial & varied client base, including multinational corporations,
financial institutions, governments, & individuals, among others.
Our specialization in niche industries
& emerging geographies allows our clients to formulate their strategies in
a much more informed way and entail parameters like Go-to-Market (GTM), product
development, feasibility analysis, project scoping, market segmentation,
competitive benchmarking, market sizing & forecasting, & trend analysis,
among others, for 15 diverse industrial verticals.
Contact
Us –
Call:
📞 +1 627 895 8081, +91 120 4278433
Email:
📧 sales@marknteladvisors.com
Visit
to know more: 🌐 https://www.marknteladvisors.com/
